Safety and Efficacy of Tisagenlecleucel in Primary CNS Lymphoma: A phase I/II clinical trial. Frigault MJ, Dietrich J, Gallagher KME, Roschewski MJ, et al. Blood 2022 Feb 15. pii: 484042. doi: 10.1182/blood.2021014738.

Read + Share

Amedeo Smart

Independent Medical Education

Frigault MJ, Dietrich J, Gallagher KME, Roschewski MJ, et al. Safety and Efficacy of Tisagenlecleucel in Primary CNS Lymphoma: A phase I/II clinical trial. Blood 2022 Feb 15. pii: 484042. doi: 10.1182/blood.2021014738.
PMID: 35167655